Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aude Fléchon

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed in genito-urinary tumors treatment]Aude Fléchon
Bulletin Du Cancer|July 5, 2020
[Intensification by high dose chemotherapy for germ-cell tumors, still an ongoing subject?]Armelle Vinceneux, Mélodie Carbonnaux, Aude Fléchon
Critical Reviews in Oncology/Hematology|May 1, 2020
Brain metastases from germ cell tumor: time to reconsider radiotherapy?Jonathan Khalifa, Aude Fléchon, Christine Chevreau
La Revue Du Praticien|April 26, 2007
[Surgery of residual masses after chemotherapy in patients with testicular cancer]Aude Fléchon, Michel Rivoire, Nicole Berger
Nature Clinical Practice. Urology|April 10, 2008
Management of advanced germ-cell tumors of the testisAude Fléchon, Michel Rivoire, Jean-Pierre Droz
Bulletin Du Cancer|July 13, 2020
[Treatment of testicular germ cell tumors relapse]Mélodie Carbonnaux, Armelle Vinceneux, Patrice Peyrat, et al.
Bulletin Du Cancer|November 21, 2002
[Management of advanced seminoma: retrospective study of 96 patients]Emmanuelle Bompas, Aude Fléchon, Pierre Biron, et al.
Bulletin Du Cancer|August 9, 2011
[High dose chemotherapy and germ cell tumor]Christophe Massard, Aude Fléchon, Karim Fizazi, et al.
Journal of Clinical Medicine|June 19, 2024
Bone Metastases in Non-Seminomatous Germ Cell Tumors: A 20-Year Retrospective AnalysisRomane Gille, Benoît Allignet, Floriane Izarn, et al.
Bulletin Du Cancer|May 26, 2019
[Securing patients pathways treated by oral antitumoral: Guidelines for better organization of departments and management of incoming calls]Aude Fléchon, Clémentine Villeminey, Frédéric Despiau, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed in genito-urinary tumors treatment]Aude Fléchon
Bulletin Du Cancer|July 5, 2020
[Intensification by high dose chemotherapy for germ-cell tumors, still an ongoing subject?]Armelle Vinceneux, Mélodie Carbonnaux, Aude Fléchon
Critical Reviews in Oncology/Hematology|May 1, 2020
Brain metastases from germ cell tumor: time to reconsider radiotherapy?Jonathan Khalifa, Aude Fléchon, Christine Chevreau
La Revue Du Praticien|April 26, 2007
[Surgery of residual masses after chemotherapy in patients with testicular cancer]Aude Fléchon, Michel Rivoire, Nicole Berger
Nature Clinical Practice. Urology|April 10, 2008
Management of advanced germ-cell tumors of the testisAude Fléchon, Michel Rivoire, Jean-Pierre Droz
Bulletin Du Cancer|July 13, 2020
[Treatment of testicular germ cell tumors relapse]Mélodie Carbonnaux, Armelle Vinceneux, Patrice Peyrat, et al.
Bulletin Du Cancer|November 21, 2002
[Management of advanced seminoma: retrospective study of 96 patients]Emmanuelle Bompas, Aude Fléchon, Pierre Biron, et al.
Bulletin Du Cancer|August 9, 2011
[High dose chemotherapy and germ cell tumor]Christophe Massard, Aude Fléchon, Karim Fizazi, et al.
Journal of Clinical Medicine|June 19, 2024
Bone Metastases in Non-Seminomatous Germ Cell Tumors: A 20-Year Retrospective AnalysisRomane Gille, Benoît Allignet, Floriane Izarn, et al.
Bulletin Du Cancer|May 26, 2019
[Securing patients pathways treated by oral antitumoral: Guidelines for better organization of departments and management of incoming calls]Aude Fléchon, Clémentine Villeminey, Frédéric Despiau, et al.
Pageof 12